Skip to main content
. 2021 Feb 1;10:585213. doi: 10.3389/fonc.2020.585213

Table 3.

The distribution of PSMA-positive lesions and FDG-positive lesions.

Distribution 18F-PSMA-1007 18F-FDG
All 124 68
metastase 75 (60%) 54 (79%)
Bone metastase 50 32
Soft tissue metastase 25 22
benign lesions 49 (40%) 14 (21%)
ganglia 17
unspecific lymph nodes 12 7
fracture 5 3
degenerative changes 5 2
unspecific soft tissue 3 2
increasly PSMA-ligand uptake without correlate on CT images 7